TTR and cancer: The prevalence and incidence of CA is increasing due to improved diagnostics and awareness of treating cardiologists, and studies have shown that TTR-amyloid deposits are the cause of cardiac insufficiency in 13-17% of patients with heart failure with preserved ejection fraction (HFpEF) [6].